国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

泰格醫藥, Tigermed ,   
杭州泰格醫藥科技股份有限公司是國內領先的臨床合同研究組織（CRO），專注于為醫藥產品研發提供I-IV期臨床試驗、數據管理與生物統計、注冊申報等全方位服務。公司自成立以來，一直致力于為客戶提供高質量和高效率的醫藥研發服務，幫助客戶降低研發風險、節約研發經費，推進產品市場化進程。

公司總部位于杭州，下設七家子公司，構筑了涵蓋臨床研究產業鏈各個環節的完整服務體系。截止2011年底，在國內40多個主要城市設有辦事機構，擁有近600人的國際化專業團隊，建立了國際標準的操作規程（SOP）。泰格醫藥已經為國內外300多家客戶成功提供了近千項臨床試驗、注冊申報、數據管理和生物統計服務。因為擁有33種創新藥（包括23種新化學單體和10個新生物制品）的臨床研究經驗與成就，泰格醫藥是國內領先的“創新型CRO”。

Hangzhou Tigermed Consulting Co., Ltd is a leading Contract Research Organization (CRO) in China dedicated to providing regulatory affairs, Phase I-IV clinical trials, data management, biostatistics, medical translation and GCP training services for healthcare products. Since inception in 2004, Tigermed has been committed to accelerating your product development timeline while reducing R&D costs and risks, helping you to bring the miracles of your new product to market effectively.

Headquartered in Hangzhou, Tigermed operates 7 subsidiaries, 40 offices in China mainland. With more than 600 staff, Tigermed has set up global Standard Operating Procedures (SOPs) and successfully serviced more than 300 local and global clients in the conduct of hundreds of regulatory affairs, clinical trials, data management and biostatistics projects. Through our unmatched experience and outstanding achievements in the development of 33 innovative drugs (23 NCEs and 10 new biological products), Tigermed is recognized as “An Innovative CRO” in China.